[Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
Bilotta
P
P
Favilli
S
S
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D017135:Desogestrel; D004338:Drug Combinations; D004341:Drug Evaluation; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007558:Italy; D008597:Menstrual Cycle / Q000187:drug effects; D009652:Norpregnenes / Q000008:administration & dosage / Q000009:adverse effects; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D009652:Norpregnenes; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; C034653:Oviol; D017135:Desogestrel
Valutazione clinica del desogestrel, primo progestinico della nuova generazione: il Practil 21 su 13.290 donne e 74.967 cicli.